These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 30487570)

  • 41. FRZB and melusin, overexpressed in LGMD2A, regulate integrin β1D isoform replacement altering myoblast fusion and the integrin-signalling pathway.
    Jaka O; Casas-Fraile L; Azpitarte M; Aiastui A; López de Munain A; Sáenz A
    Expert Rev Mol Med; 2017 Mar; 19():e2. PubMed ID: 28300015
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genetic Evidence That Captured Retroviral Envelope syncytins Contribute to Myoblast Fusion and Muscle Sexual Dimorphism in Mice.
    Redelsperger F; Raddi N; Bacquin A; Vernochet C; Mariot V; Gache V; Blanchard-Gutton N; Charrin S; Tiret L; Dumonceaux J; Dupressoir A; Heidmann T
    PLoS Genet; 2016 Sep; 12(9):e1006289. PubMed ID: 27589388
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Thyroid Hormone Receptor α Plays an Essential Role in Male Skeletal Muscle Myoblast Proliferation, Differentiation, and Response to Injury.
    Milanesi A; Lee JW; Kim NH; Liu YY; Yang A; Sedrakyan S; Kahng A; Cervantes V; Tripuraneni N; Cheng SY; Perin L; Brent GA
    Endocrinology; 2016 Jan; 157(1):4-15. PubMed ID: 26451739
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Perturbation of muscle metabolism in patients with muscular dystrophy in early or acute phase of disease: In vitro, high resolution NMR spectroscopy based analysis.
    Srivastava NK; Yadav R; Mukherjee S; Sinha N
    Clin Chim Acta; 2018 Mar; 478():171-181. PubMed ID: 29278724
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A novel in vitro model for the assessment of postnatal myonuclear accretion.
    Kneppers A; Verdijk L; de Theije C; Corten M; Gielen E; van Loon L; Schols A; Langen R
    Skelet Muscle; 2018 Feb; 8(1):4. PubMed ID: 29444710
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Signals of Ezh2, Src, and Akt Involve in myostatin-Pax7 pathways regulating the myogenic fate determination during the sheep myoblast proliferation and differentiation.
    Wei C; Ren H; Xu L; Li L; Liu R; Zhang L; Zhao F; Lu J; Zhang X; Du L
    PLoS One; 2015; 10(3):e0120956. PubMed ID: 25811841
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Genetic deletion of muscle RANK or selective inhibition of RANKL is not as effective as full-length OPG-fc in mitigating muscular dystrophy.
    Dufresne SS; Boulanger-Piette A; Bossé S; Argaw A; Hamoudi D; Marcadet L; Gamu D; Fajardo VA; Yagita H; Penninger JM; Russell Tupling A; Frenette J
    Acta Neuropathol Commun; 2018 Apr; 6(1):31. PubMed ID: 29699580
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Polycomb Ezh2 methyltransferase regulates muscle gene expression and skeletal muscle differentiation.
    Caretti G; Di Padova M; Micales B; Lyons GE; Sartorelli V
    Genes Dev; 2004 Nov; 18(21):2627-38. PubMed ID: 15520282
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Expression profiling of FSHD muscle supports a defect in specific stages of myogenic differentiation.
    Winokur ST; Chen YW; Masny PS; Martin JH; Ehmsen JT; Tapscott SJ; van der Maarel SM; Hayashi Y; Flanigan KM
    Hum Mol Genet; 2003 Nov; 12(22):2895-907. PubMed ID: 14519683
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Glucocorticoids Improve Myogenic Differentiation In Vitro by Suppressing the Synthesis of Versican, a Transitional Matrix Protein Overexpressed in Dystrophic Skeletal Muscles.
    McRae N; Forgan L; McNeill B; Addinsall A; McCulloch D; Van der Poel C; Stupka N
    Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29211034
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The lysine methyltransferase Ehmt2/G9a is dispensable for skeletal muscle development and regeneration.
    Zhang RH; Judson RN; Liu DY; Kast J; Rossi FM
    Skelet Muscle; 2016; 6():22. PubMed ID: 27239264
    [TBL] [Abstract][Full Text] [Related]  

  • 52. G9a promotes proliferation and inhibits cell cycle exit during myogenic differentiation.
    Rao VK; Ow JR; Shankar SR; Bharathy N; Manikandan J; Wang Y; Taneja R
    Nucleic Acids Res; 2016 Sep; 44(17):8129-43. PubMed ID: 27229136
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Myoblast transfer therapy: is there any light at the end of the tunnel?
    Mouly V; Aamiri A; Périé S; Mamchaoui K; Barani A; Bigot A; Bouazza B; François V; Furling D; Jacquemin V; Negroni E; Riederer I; Vignaud A; St Guily JL; Butler-Browne GS
    Acta Myol; 2005 Oct; 24(2):128-33. PubMed ID: 16550930
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Altered bone-regulating myokine expression in skeletal muscle Of Duchenne muscular dystrophy mouse models.
    Zhou S; Qian B; Wang L; Zhang C; Hogan MV; Li H
    Muscle Nerve; 2018 Oct; 58(4):573-582. PubMed ID: 30028902
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Extracorporeal circulation as a new experimental pathway for myoblast implantation in mdx mice.
    Torrente Y; D'Angelo MG; Del Bo R; DeLiso A; Casati R; Benti R; Corti S; Comi GP; Gerundini P; Anichini A; Scarlato G; Bresolin N
    Cell Transplant; 1999; 8(3):247-58. PubMed ID: 10442737
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ash1 l loss-of-function results in structural birth defects and altered cortical development.
    Toolan KP; McGrath BT; Brinkmeier ML; Camper SA; Bielas SL
    Brain; 2024 Jun; ():. PubMed ID: 38943682
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of ASH1L on neurodevelopment.
    Bakoyiannis I
    Lab Anim (NY); 2022 Mar; 51(3):77. PubMed ID: 35241855
    [No Abstract]   [Full Text] [Related]  

  • 58. Crystal Structure of the Double Homeodomain of DUX4 in Complex with DNA.
    Lee JK; Bosnakovski D; Toso EA; Dinh T; Banerjee S; Bohl TE; Shi K; Orellana K; Kyba M; Aihara H
    Cell Rep; 2018 Dec; 25(11):2955-2962.e3. PubMed ID: 30540931
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Human iPSC Models to Study Orphan Diseases: Muscular Dystrophies.
    Xia G; Terada N; Ashizawa T
    Curr Stem Cell Rep; 2018; 4(4):299-309. PubMed ID: 30524939
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Early onset as a marker for disease severity in facioscapulohumeral muscular dystrophy.
    Goselink RJM; Mul K; van Kernebeek CR; Lemmers RJLF; van der Maarel SM; Schreuder THA; Erasmus CE; Padberg GW; Statland JM; Voermans NC; van Engelen BGM
    Neurology; 2019 Jan; 92(4):e378-e385. PubMed ID: 30568007
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.